Publications by authors named "Jay Zhao"

Claim this Profile
F
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma.
Andrea C Baines, Bindu Kanapuru, Jay Zhao, Lauren S L Price, Nan Zheng

Clin Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between histopathologic effects and liver weight changes induced in mice and rats by chemical exposures: an analysis of the data from Toxicity Reference Database (ToxRefDB).
Roman Mezencev, Madison Feshuk, Lori Kolaczkowski, Geoffrey Colin Peterson, Q Jay Zhao

Toxicol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing the science of a read-across framework for evaluation of data-poor chemicals incorporating systematic and new approach methods.
Lucina E Lizarraga, Glenn W Suter, Jason C Lambert, Grace Patlewicz, Jay Q Zhao

Regul Toxicol Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case study on the application of an expert-driven read-across approach in support of quantitative risk assessment of p,p'-dichlorodiphenyldichloroethane.
Lucina E Lizarraga, Jeffry L Dean, J Phillip Kaiser, Scott C Wesselkamper, Jason C Lambert, Q Jay Zhao

Regul Toxicol Pharmacol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Highlight: Application of Gene Set Enrichment Analysis for Identification of Chemically Induced, Biologically Relevant Transcriptomic Networks and Potential Utilization in Human Health Risk Assessment.
Jeffry L Dean, Q Jay Zhao, Jason C Lambert, Belinda S Hawkins, Russell S Thomas

Toxicol Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Next Generation of Risk Assessment Multi-Year Study-Highlights of Findings, Applications to Risk Assessment, and Future Directions.
Ila Cote, Melvin E Andersen, Gerald T Ankley, Stanley Barone, Linda S Birnbaum, Jay Zhao

Environ Health Perspect· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between chemical-induced kidney weight increases and kidney histopathology in rats.
Evisabel A Craig, Zhongyu Yan, Q Jay Zhao

J Appl Toxicol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using quantitative structure-activity relationship modeling to quantitatively predict the developmental toxicity of halogenated azole compounds.
Evisabel A Craig, Nina Ching Wang, Q Jay Zhao

J Appl Toxicol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework.
Russell S Thomas, Martin A Philbert, Scott S Auerbach, Barbara A Wetmore, Michael J Devito, Q Jay Zhao

Toxicol Sci· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal concordance between apical and transcriptional points of departure for chemical risk assessment.
Russell S Thomas, Scott C Wesselkamper, Nina Ching Y Wang, Q Jay Zhao, Dan D Petersen

Toxicol Sci· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of computational toxicological approaches in human health risk assessment. I. A tiered surrogate approach.
Nina Ching Yi Wang, Q Jay Zhao, Scott C Wesselkamper, Jason C Lambert, Dan Petersen

Regul Toxicol Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
J Allen Davis, Jeffrey S Gift, Q Jay Zhao

Toxicol Appl Pharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.
Russell S Thomas, Harvey J Clewell, Bruce C Allen, Scott C Wesselkamper, Nina Ching Y Wang, Q Jay Zhao

Toxicol Sci· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis